谷歌浏览器插件
订阅小程序
在清言上使用

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Cilofexor in Patients with Non-Cirrhotic Primary Sclerosing Cholangitis (PRIMIS)

JOURNAL OF HEPATOLOGY(2023)

引用 1|浏览40
关键词
Primary Sclerosing Cholangitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要